SAN DIEGO, Feb. 22, 2017 -- The Shareholders Foundation, Inc. announces that a lawsuit was filed in Utah for certain purchasers of shares of USANA Health Sciences, Inc. (NYSE:USNA) over alleged Securities Laws Violations by USANA Health Sciences, Inc.
Investors, who purchased shares of USANA Health Sciences, Inc. (NYSE:USNA) in March 2014 or earlier and currently hold any of those NYSE: USNA shares, have certain options and should contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554.
On August 16, 2010, USANA Health Sciences, Inc. announced that it had acquired BabyCare Ltd., a China-based manufacturing company that develops and sells nutritional products primarily for infants.
Over the next six years, USANA Health Sciences, Inc. steadily expanded BabyCare Ltd.’s market presence in China.
In February 2013, the Company announced that it had received official government approval from the Ministry of Commerce People’s Republic of China for direct selling activities in the provinces of Jiangsu and Shaanxi, and the municipality of Tianjin.
In May 2016, USANA Health Sciences, Inc. announced Ministry of Commerce People’s Republic of China approval for direct selling activities in the provinces of Liaoning, Shandong, Shanxi, Sichuan, and Guangdong, as well as the municipalities of Dalian, Qingdao, and Shenzhen.
The plaintiff claims that the defendants made false and/or misleading statements and/or failed to disclose that the Company’s BabyCare subsidiary had engaged in improper reimbursement practices in China, that these practices constituted violations of the Foreign Corrupt Practices Act (“FCPA”), that as such, the Company’s China revenues were in part the product of unlawful conduct and unlikely to be sustainable, that the foregoing conduct, when it became known, was likely to subject the Company to significant regulatory scrutiny, and that as a result of the foregoing, USANA Health Sciences’ public statements were materially false and misleading at all relevant times.
On February 7, 2017, USANA Health Sciences, Inc. disclosed that "[t]he Company is voluntarily conducting an internal investigation of its China operations, BabyCare Ltd. . . . focus[ing] on the compliance with the Foreign Corrupt Practices Act . . . and certain conduct and policies at BabyCare, including BabyCare's expense reimbursement policies."
Those who purchased shares of USANA Health Sciences, Inc. (NYSE:USNA) in March 2014 or earlier and currently hold any of those NYSE: USNA shares should contact the Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
CONTACT: Shareholders Foundation, Inc. Michael Daniels +1 (858) 779-1554 [email protected] 3111 Camino Del Rio North Suite 423 San Diego, CA 92108


Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Novo Nordisk Warns of Profit Decline as Wegovy Faces U.S. Price Pressure and Rising Competition
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Instagram Outage Disrupts Thousands of U.S. Users 



